Summary: A time-saving protein binding assay for the simultaneous determination of cGMP and cAMP has been adapted for human urine, using [ 
Introduction
The determination of guanosine 3':5'-monophosphate (cGMP) and adenosine 3':5'-rnonophosphate (cAMP) is now performed routinely in many laboratories (1) (2) (3) and there is an increasing demand for time-saving simultaneous assays for both cyclic nucleotides (e. g. in urine), with respect to their use in clinical diagnosis. Recently two simultaneous protein binding assays have been described, one using binding protein fractions from bovine skeletal and lobster muscles (4), the other using extracts from beef adrenal cortex and the fat body of silkworm pupae (5) . Both methods employ *B-and 32 P4abeled cyclic nucleotides in almost equimolar concentrations; the latter isotope^ however, is very unstable on account of its short halflife value. Moreover, in the first procedure (4) the protein-nucleotide complexes were collected on cellulose ester filters, which requires a time consuming special filtration technique; the second procedure (5) used the precipitation technique with ammonium sulfate, which in turn requires time consuming washing and transfer processes for the protein-nucleotide complexes. Therefore in this paper we describe a simple simultaneous protein binding assay with stable 3 HU and 14 C-labeled cyclic nucleotides, using the time saving charcoal absorption technique, which requires only one centrifugation step. The assay has been adapted for the concentrations of cAMP and cGMP in human urine which exhibit a molar ratio of 5-10 to 1 (1-3). A preliminary report has been given in I.e. (6).
Materials and Methods
All labeled compounds came from Amersham-Buchler, Braunschweig, and NEN, Dreieichenhain, G.F.R., and were declared with a radio-chemical purity of 97-99%; [adenine-U- 14 ClcAMP exhibits some chemical impurity of adenosine 5-monophosphate. All cyclic nucleotides and biochemicals were perchased from Boehringer, Mannheim, and the chemicals from E. Merck, Darmstadt, G.F.R. Norit A 3 was obtained from Norit Clydesdale, Glasgow, U. K.; it was suspended in double distilled water (l g to 50 ml), centrifuged at 7800 £ and the residue dried for further use. Bovine serum albumin was purchased from Behringwerke Marburg/L. and treated (7) to remove lipids and fatty acids. Urines of healthy persons were collected with theophylline during 24 h and immediately analysed.
Preparation and characterization of binding proteins cAMP and cGMP binding protein fractions were prepared from calf skeletal muscle and from lobster tail muscle respectively; they were further purified by chromatography on DEAE<cellulosc (Whatman DE 11) as described ( (8) and (9), respectively). The isolated peak II-and peak I-fractions were dialysed 
Results and Discussion
Conditions of the simultaneous protein binding assay Conditions similar those described byDinnendahl (11) for the cGMP binding assay were used. Therefore the conditions for the cAMP binding assay reported by Brown et al. (12) had to be changed with respect to the concentration of Tris-HCl buffer, which was increased (table 1) . Furthermore, MgSO 4 was added and the concentration of 2-mercaptoethanol increased. Theophylline was replaced by SQ 20.009 (l-ethyl-4-(isopropylidene-hydrazino)-l H-pyrazolol[3 ,-4-b] pyridine-5-carboxylic acid, a kind gift from Squibb, Princeton, N. J., U.S.A.), which is reported to inhibit the phosphodiesterase activity sixty-fold more than theophylline (13) . Table 1 demonstrates that the altered conditions (especially SQ 20.009) do not influence significantly the amount of bound radioactivity nor the apparent dissociation constant of cAMP. Moreover, the conditions described with D in table 1 Having combined both fractions of binding protein for the simultaneous assay, the apparent dissociation constant increased about 10 to 20 times with respect to cAMP binding and different charges of binding protein fractions. This obviously unspecific effect, also described for albumin (4, 14) , was not altered by adding increasing amounts of cAMP. Under both conditions similar dosebinding curves were obtained (fig. 2) . The apparent dissociation constant for cGMP was neither altered by the presence of skeletal muscle binding protein (cf. The simultaneous protein binding assay for cGMP and cAMP described here has, however, one important disadvantage in comparison to those using 
Accuracy
The simultaneous recovery (n = 45) of 20 pmol cAMP and 2 pmol cGMP in urine samples exhibits values between 89% and 111% and 92% and 108%, respectively. Comparing the results of two urines measured by individual binding assays for cGMP (cf. 1. c. (11)): 1000; 330 nmol/1) and for cAMP (cf. 1. c. (12)): 6.70; 2.90 μιτιοΐ/ΐ) with those determined by the simultaneous binding assay (cGMP: 1050; 340 nmol/1; cAMP: 6.30; 2.80 jumol/l) the values are in accordance below the 10% limit. Furthermore, the data for two urines obtained in the presence of both binding proteins correspond well (below the 10% limit) with those measured by the simultaneous binding assay: for cAMP: 6.26 (8.51) and 6.88 (8.23) μπιοΐ/ΐ; for cGMP: 585 (948) and 594 (888) nmol/1.
Precision
The coefficient of variation from day to day (10 different experiments) ranges between 8 to 10% for cGMP and between 5 to 12% for cAMP, when both nucleotides were estimated simultaneously in molar cGMP to cAMP ratios of 1 to 2.5 and 1 to 40. Similar coefficients of variation are exhibited by the recovery experiments with a molar ratio of cyclic nucleotides of 1 to 20 as demonstrated above. The coefficient of variation within series shows somewhat lower values: 5 to 8% and 5 to 9%, respectively. Specificity Although, in the simultaneous assay, cAMP is bound by two different binding protein fractions, log-log plots of the dose-binding curves are linear, and they do not show any disturbance with increasing concentrations of cGMP (5-160 nmol/1, figs. 2, 3). 10 times higher concentrations of cGMP begin to displace cAMP from skeletal muscle binding protein. cGMP is only bound by the protein fraction from lobster muscle; however, cAMP concentrations > 400 nmol/1 begin to displace labeled cGMP, thus exhibiting a 50 to 100 times higher value for the apparent dissociation constant. Therefore urine samples have to be diluted 10 to 20 times with buffer Ρ (table 1) ; otherwise cGMP values must be corrected (e. g.: 500 nmol/1 cAMP displacẽ 1.0 nmol/1 cGMP, 800 ~ 2.6,1600 ~* 6.8; conditions of fig. 2 ). Nevertheless, in the diluted urine samples the cGMP concentration appears to be high enougji for its exact measurement.
Interference
Interference by corresponding purine bases, nucleosides or nucleotides (e. g. adenosine-(guanosine^)mono-, di-, triphosphate) occurs with 10 to 1000 times higher concentrations than are to be expected in the test (cf. 1. c. (11, 12,15, 17) ). To exclude a chemical .interference, individual blanks of the diluted urine samples are used, and generally they have proved to be low.
Cyclic nucleotide levels in 12 human urines were measured by the simultaneous binding assay (conditions see fig. 3 ) and related to the urine volume excreted during 24 h or to 1 mol creatinine (determined with the Technicon Autoanalyzer). In 5 healthy men (44 ± 9 years old) the value for cAMP was 6.73 ± 2.12 μπιοΙ/24 h (0.169 ± 0.043 mmol/mol creatinine) and for cGMP 649 ± 179 nmol/24 h (16.3 ± 3.2 μπιοΐ/rri l creatinine), in 7 healthy women (38 ± 12 years old) 5.51 ± 1.03 (0.191 ± 0.047) and 648 ± 219 (22.6 ± 6.2). The data correspond well with those determined by other procedures (cf. 1. c. (1, 3, 14) ). Summing up, although the counting (and binding) yields are low with respect to [ 14 C]cAMP, the precision, accuracy and recovery of the simple simultaneous protein binding assay adapted for human urine are quite satisfactory for cAMP and cGMP, and they are comparable to those of other individual or simultaneous techniques already described (1, 3,14; 4) . The timesaving assay (up to 50 samples may be analysed in triplicate per day) appears to considerably lower the cost, compared with commercially available individual protein binding assays. C-adenine]cAMP offered in the test are bound, so that the radioactive counts obtained are at least two times higher than described, indicating now a better sensitivity of the test.
